Novartis CEO warns reality of Trump's drug pricing policy will set in over 'the next 18 months'

Novartis' CEO warned Tuesday that U.S. drug pricing policy under President Donald Trump poses a "very difficult situation." ...
The Hill

White House to launch TrumpRx platform, revealing results of Trump’s MFN policy

The White House is planning to officially launch its direct-to-consumer, lower-cost drug platform TrumpRx Thursday evening, unveiling the results of President Trump’s “most favored nation” (MFN) drug ...